Chen‐Yi Cheung

895 total citations
32 papers, 596 citations indexed

About

Chen‐Yi Cheung is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Chen‐Yi Cheung has authored 32 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Chen‐Yi Cheung's work include Tuberculosis Research and Epidemiology (18 papers), Mycobacterium research and diagnosis (10 papers) and Cancer therapeutics and mechanisms (9 papers). Chen‐Yi Cheung is often cited by papers focused on Tuberculosis Research and Epidemiology (18 papers), Mycobacterium research and diagnosis (10 papers) and Cancer therapeutics and mechanisms (9 papers). Chen‐Yi Cheung collaborates with scholars based in New Zealand, Australia and United States. Chen‐Yi Cheung's co-authors include Gregory M. Cook, Matloob Husain, Matthew B. McNeil, Kiel Hards, Bridget L. Stocker, Mattie S. M. Timmer, Kyu Y. Rhee, Michael J. Kelso, Adam Heikal and Shyamal C. Das and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Virology.

In The Last Decade

Chen‐Yi Cheung

30 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chen‐Yi Cheung New Zealand 15 343 222 170 91 76 32 596
Lisa K. Woolhiser United States 15 255 0.7× 363 1.6× 230 1.4× 127 1.4× 55 0.7× 18 634
Jiuyu Liu United States 14 388 1.1× 323 1.5× 166 1.0× 170 1.9× 52 0.7× 42 736
Monika Jankute United Kingdom 10 263 0.8× 240 1.1× 218 1.3× 70 0.8× 61 0.8× 13 534
Frédéric Frénois France 12 418 1.2× 224 1.0× 133 0.8× 37 0.4× 97 1.3× 23 658
Arundhati Maitra United Kingdom 14 293 0.9× 322 1.5× 196 1.2× 148 1.6× 56 0.7× 33 646
Pooja Gopal Singapore 17 461 1.3× 354 1.6× 266 1.6× 84 0.9× 62 0.8× 21 712
Joseph Cherian Singapore 14 520 1.5× 399 1.8× 274 1.6× 146 1.6× 82 1.1× 25 920
Hendrik Koliwer‐Brandl Germany 16 379 1.1× 121 0.5× 130 0.8× 179 2.0× 31 0.4× 31 638
Xingji Zheng Canada 9 309 0.9× 337 1.5× 268 1.6× 47 0.5× 44 0.6× 11 583
Raju S Rajmani India 15 350 1.0× 388 1.7× 268 1.6× 41 0.5× 85 1.1× 45 702

Countries citing papers authored by Chen‐Yi Cheung

Since Specialization
Citations

This map shows the geographic impact of Chen‐Yi Cheung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen‐Yi Cheung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen‐Yi Cheung more than expected).

Fields of papers citing papers by Chen‐Yi Cheung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen‐Yi Cheung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen‐Yi Cheung. The network helps show where Chen‐Yi Cheung may publish in the future.

Co-authorship network of co-authors of Chen‐Yi Cheung

This figure shows the co-authorship network connecting the top 25 collaborators of Chen‐Yi Cheung. A scholar is included among the top collaborators of Chen‐Yi Cheung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen‐Yi Cheung. Chen‐Yi Cheung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, Chen‐Yi, et al.. (2025). Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria. Nature Communications. 16(1). 11018–11018.
2.
Trani, Justin M. Di, Ana Rodrı́guez, Chen‐Yi Cheung, et al.. (2025). Cryo-EM of native membranes reveals an intimate connection between the Krebs cycle and aerobic respiration in mycobacteria. Proceedings of the National Academy of Sciences. 122(8). e2423761122–e2423761122. 2 indexed citations
3.
Wang, Cecilia, Chen‐Yi Cheung, Boatema Ofori-Anyinam, et al.. (2024). Whole genome CRISPRi screening identifies druggable vulnerabilities in an isoniazid resistant strain of Mycobacterium tuberculosis. Nature Communications. 15(1). 9791–9791. 12 indexed citations
4.
Cheung, Chen‐Yi, et al.. (2023). The evolution of antibiotic resistance is associated with collateral drug phenotypes in Mycobacterium tuberculosis. Nature Communications. 14(1). 1517–1517. 40 indexed citations
5.
Kalia, Nitin Pal, Samsher Singh, Kiel Hards, et al.. (2023). M. tuberculosis relies on trace oxygen to maintain energy homeostasis and survive in hypoxic environments. Cell Reports. 42(5). 112444–112444. 21 indexed citations
6.
Cheung, Chen‐Yi, Matthew B. McNeil, Kiel Hards, et al.. (2023). A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis. Cell chemical biology. 31(4). 683–698.e7. 12 indexed citations
7.
Cheung, Chen‐Yi, Gregory M. Cook, George Taiaroa, et al.. (2022). RNase HI Depletion Strongly Potentiates Cell Killing by Rifampicin in Mycobacteria. Antimicrobial Agents and Chemotherapy. 66(10). e0209121–e0209121. 1 indexed citations
8.
Zhou, Yang, Min Shao, Weiwei Wang, et al.. (2022). Discovery of 1-hydroxy-2-methylquinolin-4(1H)-one derivatives as new cytochrome bd oxidase inhibitors for tuberculosis therapy. European Journal of Medicinal Chemistry. 245(Pt 1). 114896–114896. 11 indexed citations
9.
McNeil, Matthew B., Chen‐Yi Cheung, Zhengqiu Li, et al.. (2022). Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis. Frontiers in Cellular and Infection Microbiology. 12. 980844–980844. 6 indexed citations
10.
McNeil, Matthew B., et al.. (2021). CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis. Molecular Microbiology. 116(4). 1033–1043. 24 indexed citations
11.
McNeil, Matthew B., et al.. (2021). Multiplexed transcriptional repression identifies a network of bactericidal interactions between mycobacterial respiratory complexes. iScience. 25(1). 103573–103573. 10 indexed citations
12.
Wu, Yu, Chen‐Yi Cheung, Yang Zhou, et al.. (2021). Discovery of 5-methylpyrimidopyridone analogues as selective antimycobacterial agents. Bioorganic & Medicinal Chemistry. 49. 116426–116426. 1 indexed citations
13.
Cheung, Chen‐Yi, Matthew B. McNeil, & Gregory M. Cook. (2021). Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection. Journal of Antimicrobial Chemotherapy. 77(3). 615–619. 16 indexed citations
14.
Ferguson, Scott, Chen‐Yi Cheung, Michelle McConnell, et al.. (2019). Microtiter Screening Reveals Oxygen-Dependent Antimicrobial Activity of Natural Products Against Mastitis-Causing Bacteria. Frontiers in Microbiology. 10. 1995–1995. 5 indexed citations
15.
Hards, Kiel, Liam K. Harold, Matthew B. McNeil, et al.. (2019). Two for the price of one: Attacking the energetic-metabolic hub of mycobacteria to produce new chemotherapeutic agents. Progress in Biophysics and Molecular Biology. 152. 35–44. 20 indexed citations
16.
Cheung, Chen‐Yi, et al.. (2019). The synthesis and evaluation of quinolinequinones as anti-mycobacterial agents. Bioorganic & Medicinal Chemistry. 27(16). 3532–3545. 22 indexed citations
17.
Saw, Wuan Geok, Priya Ragunathan, Goran Biuković, et al.. (2019). Disrupting coupling within mycobacterial F-ATP synthases subunit ε causes dysregulated energy production and cell wall biosynthesis. Scientific Reports. 9(1). 16759–16759. 29 indexed citations
18.
Buckley, Benjamin J., Longguang Jiang, Chen‐Yi Cheung, et al.. (2019). 6-Substituted amiloride derivatives as inhibitors of the urokinase-type plasminogen activator for use in metastatic disease. Bioorganic & Medicinal Chemistry Letters. 29(24). 126753–126753. 17 indexed citations
19.
Lu, Xiaoyun, Kiel Hards, Chen‐Yi Cheung, et al.. (2018). Pyrazolo[1,5-a]pyridine Inhibitor of the Respiratory Cytochrome bcc Complex for the Treatment of Drug-Resistant Tuberculosis. ACS Infectious Diseases. 5(2). 239–249. 69 indexed citations
20.
Heikal, Adam, Kiel Hards, Chen‐Yi Cheung, et al.. (2016). Activation of type II NADH dehydrogenase by quinolinequinones mediates antitubercular cell death. Journal of Antimicrobial Chemotherapy. 71(10). 2840–2847. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026